Latest News and Press Releases
Want to stay updated on the latest news?
-
TORONTO, April 15, 2025 (GLOBE NEWSWIRE) -- Blue Moon Metals Inc. (“Blue Moon” or the “Company”) (TSXV: MOON; OTCQX: BMOOF) is pleased to announce that its common shares are now trading on the...
-
DENVER, Jan. 16, 2025 (GLOBE NEWSWIRE) -- American Rare Earths (ASX: ARR | OTCQX: ARRNF | ADR: AMRRY) (“ARR” or the Company) is proud to announce its recognition in the 2025 OTCQX® Best 50, a...
-
SHENZHEN, China, July 10, 2024 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (OTCQX: PAIYY) (the “Company” or “AIH”), a leading provider of aesthetic medical services in...
-
Optimi Health Congratulates Lykos Therapeutics on FDA Priority Review of New Drug Application And Releases MDMA Production Video
-
Optimi Announces Non-Brokered Private Placement
-
Repeated recognition demonstrates Xtract One Technologies' continued growth and industry strength.
-
Glenwood Springs, Colo., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Alpine Banks of Colorado (OTCQX: ALPIB) announced today that a quarterly cash dividend of $0.20 per Class B nonvoting common share will be...
-
Aduro announced that it has upgraded its trading tier on the OTC Markets to the OTCQX® Best Market from the OTCQB® Venture Market.
-
VANCOUVER, British Columbia, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, is pleased...
-
VANCOUVER, British Columbia, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, proudly...